MLchartDataset catalogue

Xofigo

Term · Oncology and biomedicine · MLC-T-ONC-009416

A radioactive drug used to treat prostate cancer that has spread to the bone and is causing symptoms but has not spread to other organs. It is used in patients whose cancer is castration resistant (has not responded to treatments that lower testosterone levels). It is also being studied in the treatment of other types of cancer. Xofigo contains a radioactive substance called radium Ra 223. It collects in bone and gives off radiation that may kill cancer cells. Xofigo is a type of radiotherapeutic agent. Also called radium Ra 223-dichloride.

Table 1. Record
IdentifierMLC-T-ONC-009416
FieldOncology and biomedicine
Synonymsradium Ra 223-dichloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009416",
  "term": "Xofigo",
  "field": "Oncology and biomedicine",
  "definition": "A radioactive drug used to treat prostate cancer that has spread to the bone and is causing symptoms but has not spread to other organs. It is used in patients whose cancer is castration resistant (has not responded to treatments that lower testosterone levels). It is also being studied in the treatment of other types of cancer. Xofigo contains a radioactive substance called radium Ra 223. It collects in bone and gives off radiation that may kill cancer cells. Xofigo is a type of radiotherapeutic agent. Also called radium Ra 223-dichloride.",
  "synonyms": [
    "radium Ra 223-dichloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/xofigo/"
}

Record 17,505 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.